Haisco Pharmaceutical Group Co., Ltd.
002653
Classifica tra le azioni
#2069
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Prezzo delle azioni
$8.74
Capitalizzazione di mercato
$9.97B
Variazione (1 giorno)
1.17%
Variazione (1 anno)
20.15%
Paese
CN
Scambia Haisco Pharmaceutical Group Co., Ltd. (002653)
Categoria
Healthcare
Rapporto P/B per Haisco Pharmaceutical Group Co., Ltd. (002653)
Rapporto P/B al October 2026 TTM: 12.97
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Haisco Pharmaceutical Group Co., Ltd., il rapporto P/B attuale (TTM) è 12.97. Alla fine del 2023, era pari a 6.30.
Storico del rapporto P/B per Haisco Pharmaceutical Group Co., Ltd. da 2008 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 12.97 | 46.74% |
| 2024 | 8.84 | 40.24% |
| 2023 | 6.30 | -20.06% |
| 2022 | 7.88 | 2.00% |
| 2021 | 7.73 | 19.70% |
| 2020 | 6.46 | -29.69% |
| 2019 | 9.18 | 53.03% |
| 2018 | 6.00 | 4.90% |
| 2017 | 5.72 | -22.51% |
| 2016 | 7.38 | -31.60% |
| 2015 | 10.79 | 23.70% |
| 2014 | 8.72 | -21.38% |
| 2013 | 11.10 | 72.12% |
| 2012 | 6.45 | -27.45% |
| 2011 | 8.89 | -39.72% |
| 2010 | 14.74 | -68.96% |
| 2009 | 47.50 | 59.68% |
| 2008 | 29.74 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.251 | -51.81% |
US
|
|
| 13.2547 | 2.18% |
US
|
|
| 4.208 | -67.56% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -52.34% |
NL
|
